Areteia Therapeutics

About:

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.

Website: https://areteiatx.com

Twitter/X: aristeatx

Top Investors: Google Ventures, Sanofi, ARCH Venture Partners, Bain Capital Life Sciences, Viking Global Investors

Description:

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease. The company was spun out of Pennsylvania-based Knopp, which published results from its phase 2 clinical trial last year that showed its oral drug candidate could reduce the count of blood eosinophil, which is an indication of improving lung function and is found in several asthma-related treatments.

Total Funding Amount:

$425M

Headquarters Location:

Bernardsville, New Jersey, United States

Founded Date:

2022-01-01

Contact Email:

info(AT)areteiatx.com

Founders:

Christopher Courts, Jorge Bartolome, Whit Bernard

Number of Employees:

11-50

Last Funding Date:

2024-02-13

IPO Status:

Private

© 2025 bioDAO.ai